Data from health insurer reporting in 2021 is now available.
Health insurance companies in Oregon are required through the rate review process to provide information on the top 25 drugs for various categories: most frequently prescribed, most costly, and those causing the greatest increase in plan spending.
Also, health insurance companies are required to report on the effect of prescription drug costs on premiums, including any effect that rebates or price concessions may have on premiums. The lists submitted by the health insurance companies used the template provided below. The information reported to the program was used to compile the aggregate prescription drugs lists below.
Insurer report data
The program received reports from those health insurance companies that participate in Oregon's annual rate review process, usually nine or 10 companies. Check the program's annual legislative report for details about the data collected from these insurance companies.
2019 Insurer prescription drug reports